DUAL DIAGNOSIS VIDEO MATERIALS

1. Dual Diagnosis: An Integrated Model for Treatment. Kenneth Minkoff, MD. Mental Illness Education Project. phone 800-343-5540.
2. Promise of Recovery. Gerald T. Rogers Productions. 800-227-9100.
3. Double Trouble. Gerald T. Rogers Productions.800-227-9100.
4. Dual Diagnosis.(1994) NIDA, Rockville, MD.
5. Understanding Depression and Addiction.
6. Understanding Major Anxiety Disorders and Addiction.
7. Understanding Personality Problems and Addiction.
8. Understanding Posttraumatic Stress Disorder and Addiction.
9. Understanding Bipolar Disorder and Addiction (Dual Diagnosis Series), Hazelden
10.Out of the Tunnel; Into the Light. Hazelden. 800-328-9000.
11. 12 Steps & Dual Disorders. Hazelden.800-328-9000.

RESOURCE BIBLIOGRAPHY

1. American Association of Community Psychiatrists, Level of Care Utilization System (LOCUS 2.001), Dallas, AACP 2000.
2. American Association of Community Psychiatrists, Principles for the care and treatment of individuals with co-occurring psychiatric and substance disorders. Dallas, AACP 2000. (AACP web site: www.comm.psych.pitt.edu)
3. American Society of Addiction Medicine. Patient Placement Criteria 2R. Washington, DC, ASAM. 2001.
4. Adelman S, Fletcher K, & Bahnassi A. Pharmacotherapeutic management strategies for mentally ill substance abusers. J. Subst. Abuse. Treatment. (1993) 10: 353-8.
5. Albanese M, Khantzian E, et al. Decreased substance use in chronically psychotic patients treated with clozapine. Am. J. Psych. (1994) 151:780-1.
6. Alexander MJ. Women with co-occurring disorders: an emerging profile of vulnerability. Am. J. Orthopsychiatry. (1996) 66:61-70.
7. Alexander MJ & Haugland G. Integrating services for co-occurring disorders: final report for NY State Conference of Local Mental Hygiene Directors. Nathan Kline Institute, Orangeburg, NY. March, 2000. See Appendix A: Assessment Tools.
8. Arbour Health System. Required basic competencies in addiction/dual diagnosis for adult/child clinicians, and self-learning workbook and examination. Arbour Health System. Jamaica Plain, MA 2000
9. Barreira, P, Espey, E, et al. Linking substance abuse and serious mental illness service delivery systems: initiating a statewide collaborative. Journal of Beh Health Serv Res, 2000. 27: 107-13.
10. Bastiaens, L, Francis G, & Lewis, K. The RAFFT as a screening tool for adolescent substance use disorders. Am. J. Addictions. (2000) 9:10-16.
11. Baker, J & Rohacek, J. Integrated Dual Recovery Program. McPike Addiction Treatment Center & Mohawk Valley Psychiatric Center. Utica, NY 2000.
12. Bellack AS, et al. Behavioral treatment for substance abuse in schizophrenia (BTSAS). Abellack@umaryland.edu.
13. Bellack AS & DiClemente CC. Treating substance abuse among patients with schizophrenia. Psych Services (1999) 50:75-80.
14. Biederman, J, Wilens, T, et al. Pharmacotherapy of ADHD reduces risk for substance use disorder. Pediatrics (1999).104(2).
15. Brady, KT. Co-morbidity of substance use and axis I psychiatric disorders. Medscape Mental Health 3(4) 1998. www.medscape.com.
16. Brady KT & Roberts J. The pharmacotherapy of dual diagnosis. Psych Annals (1995) 25:344-52.
17. Bricker, M. STEMSS. Milwaukee, 1988.
18. Brunette, M, & Drake, RE. Gender differences in homeless persons with schizophrenia and substance abuse. Comm MH Journal (1998).34:627-33.
19. Carey KB. Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Comm MHJ (1996) 32:291-306.
20. Carey KB, Bradizza CM, et al. The case for enhanced addictions training in graduate programs. Behavior Therapist (1999) 22:27-31.
21. Center For Substance Abuse Treatment. Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol #35. CSAT, Washington, 1999.
22. Center for Substance Abuse Treatment. Treatment of Persons with co-occurring disorders: program examples. SSDP V Co-occurring Institute. Orlando, 2000. (Contact Carol Coley: ccoley@samhsa.org)
23. Ciraulo, DA & Nace, EP. Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Am. J. Addictions (2000) 9:276-84.
24. Cline, C. Enhancing care for individuals with co-occurring psychiatric and substance use disorders. New Mexico DOH/BHSD. Santa Fe, 2001.
25. Comtois KA, Ries R, & Armstrong HE. Case manager ratings of the clinical status of dually diagnosed outpatients. Hospital and Comm. Psych. (1994) 45:568-73.
26. Drake, RE, Bartels, SJ, et al. Treatment of substance abuse in severely mentally ill patients. J. Nervous Mental Disease (1993) 181:606-11.
27. Drake, RE, Essock, SM, et al. Implementing Dual Diagnosis services for clients with severe mental illness. Psych Services (2001) 52(4).
28. Drake, RE, Mercer-McFAdden, C, et al (eds.) Readings in Dual Diagnosis. International Association of Psychosocial Rehabilitation Services. Columbia, MD. 1998.
29. Ekleberry, SC. Personality Disorders and Addiction. sekleberry@hotmail.com. Materials available on Dual Diagnosis Website: www.toad.net/~arcturus/dd/ddhome.htm.
30. Evans K & Sullivan JM. Treating Addicted Survivors of Trauma. Guilford, New York. 1995.
31. Evans K & Sullivan JM. Dual diagnosis: Counseling the Mentally Ill Substance Abuser. 2nd Edition. Guilford, New York. 2001.
32. Federation of Families for Children's Mental Health. Blamed and ashamed: the treatment experiences of youth with co-occurring disorders and their families. October, 2000.
33. Godley SH, Finch M, et al. Case management for dually diagnosed individuals involved in the criminal justice system. J. Sub Ab. Treatment.(2000) 18:137-48.
34. Goldfinger, SM, Shute, RK, et al. Housing placement and subsequent days homeless among formerly homeless adults with mental illness. Psych Services (1999) 50:674-9.
35. Hamilton, T. & Samples, P. The 12 Steps and Dual Disorders. Hazelden, Center City, MN. 1995.
36. Harris M. Trauma Recovery and Empowerment Manual. Free Press. New York. 1998.
37. Illinois Alcohol and Other Drug Abuse Professional Certification Association. The Illinois standard for board registered MI/SA I/II. IAODAPCA, Springfield, IL. 1998.
38. Illinois MISA Institute. Program Development and Cross Training for Dual Disorders. The Illinois MISA Newsletter 2(2): 1-4. 2000.
39. Kessler RC, Nelson CB et al. The epidemiology of co-occurring addictive and mental disorders. Am. J. Orthopsychiatry. (1996) 66:17-31.
40. Kosten, TR. Management of anxiety in substance abusers. American Academy of Addiction Psychiatry Newsletter. Spring, 2000. AAAP, Prairie Village, KS.
41. Leshner AI. Addiction is a brain disease, and it matters. Science (1997) 278:45-7
42. Lucksted, A, Dixon, L, & Sembly, JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation patients. Psych Services(2000). 51:1544-8.
43. Massaro, J. Substance Abuse and Mental/Emotional Disorders: Counselor Training Manual. The Information Exchange, New City, NY. 1995.
44. McKillip, R. The Basics: a curriculum for co-occurring mental health and substance use disorders. In press. Available from author: 509-258-7314.
45. Mehr, J. State of Illinois Second Task Force Report on MI/SA Dual Disorders. Illinois Offices of Mental Health and Alcoholism and Substance Abuse, Springfield, IL. May, 1998.
46. Mercer-McFadden C, Drake RE, et al. Substance Abuse Treatment for People with Severe Mental Disorders: a program manager's guide. NH-Dartmouth Psychiatric Research Center, Concord, NH. 1998.
47. Mid-America Addiction Technology Transfer Center. A Collaborative Response: Addressing the needs of consumers with co-occurring substance use and mental health disorders. (including: Psychotherapeutic Medications 2000: what every counselor should know). Kansas City, Missouri, 2000. Web site: www.mattc.org., e-mail: atc@mattc.org, phone: 816-482-1100.
48. Miller, WR & Rollnick S. Motivational Interviewing. Guilford Press, New York. 1991.
49. Minkoff, K. CHOICE-Dual. Choate Outline for Intensity of Care Evaluations for Dual Diagnosis Services. 1997. Unpublished.
50. Minkoff, K. MIDAS: Mental illness drug and alcohol screening tool. 2001. Unpublished.
51. Minkoff, K, Chair. CMHS Managed Care Initiative Panel on Co-occurring Disorders. Co-occurring psychiatric and substance disorders in managed care systems: annotated bibliography. Center for Mental Health Policy and Services Research, Philadelphia, 1997. Web site: www.med.upenn.edu/cmhpsr
52. Minkoff, K. Chair. CMHS Managed Care Initiative Panel on Co-occurring Disorders Co-occurring psychiatric and substance disorders in managed care systems: standards of care, practice guidelines, workforce competencies, and training curricula. Center for Mental Health Policy and Services Research. Philadelphia, 1998. Web site: www.med.upenn.edu/cmhpsr
53. Minkoff, K. Model for the desired array of services and clinical competencies for a comprehensive, continuous, integrated system of care. Center for Mental Health Services Research, University of Mass. Dept. of Psychiatry. Worcester, MA, 1999.
54. Minkoff, K. An integrated model for the management of co-occurring psychiatric and substance disorders in managed care systems. Dis. Mgt & Health Outcomes (2000).8(5):251-7.
55. Minkoff, K. State of Arizona Service Planning Guidelines: Co-occurring Psychiatric and Substance Disorders. 2000. (Draft).
56. Minkoff, K & Cline, C. New Mexico Co-occurring Disorders Program Competency Assessment Tool. Santa Fe. 2001..
57. Minkoff, K & Drake, RE. Homelessness and dual diagnosis. In Lamb, HR (ed). Treating the Homeless Mentally Ill. Washington, DC, APPI. 1994. 221-35.
58. Minkoff, K & Regner, J. Innovations in integrated dual diagnosis treatment in public managed care: the Choate dual diagnosis case rate program. J.Psychoactive Drugs. (1999). 31(1): 3-11.
59. Mueser, KT, Bennett, M, & Kushner, MG. Epidemiology of substance use disorders among persons with chronic mental illnesses. In. Lehman, A & Dixon, LJ. Double Jeopardy. Chronic Mental Illness and Substance Use Disorders. Harwood Academic Publishers, Chur, Switzerland.. 1995.
60. Mueser, KT, Drake, RE, & Wallach, MA. Dual diagnosis: a review of etiological theories. Addictive Behaviors (1998) 23:717-34.
61. Mueser KT & Fox L. Stagewise Family Treatment for Dual Disorders: Treatment Manual. NH Dartmouth Psychiatric Research Center, Concord, NH. 1998.
62. Mueser, KT & Noordsy, DL. Group treatment for dually diagnosed clients. In Drake, RE & Mueser, KT. Dual diagnosis of major mental illness and substance disorder. Part 2. Jossey-Bass, San Francisco. 1996.
63. Mueser, KT, Noordsy, DL, Drake, RE, Fox, L. Integrated Treatment for Dual Disorders: Effective Intervention for Severe Mental Illness and Substance Abuse. New Hampshire Dartmouth Psychiatric Research Center. In press.
64. Mueser KT, Noordsy DL, & Essock S. Use of disulfiram in the treatment of patients with dual diagnosis. Am. J. Addictions (2001) In press.
65. Najavits L, Weiss R, & Liese J. Group cognitive behavioral therapy for women with PTSD and substance use disorder. J. Subst Abuse Treatment (1996) 13:13-22.
66. Najavits L, Weiss R, et al. Seeking Safety: Outcome of a new cognitive behavioral psychotherapy for women with post-traumatic stress disorder and substance dependence. (1998)
67. NAMI. Position Statement: Integrated treatment and blended funding for co-occurring disorders. NAMI, Arlington, VA.
68. NASMHPD/NASADAD. The new conceptual framework for co-occurring mental health and substance use disorders. Washington, DC. NASMHPD 1998.
69. NASMHPD/NASADAD. Financing and marketing the new conceptual framework. Washington, NASMHPD. 2000.
70. National GAINS Center. The Courage to Change: Communities to create integrated services for people with co-occurring disorders in the justice system. GAINS Center, Delmar, NY. 1999.
71. Oregon DHS Statewide Task Force on Dual Diagnosis. Final Report and Recommendations. Oregon DHS DMH, Salem, OR. May, 2000.
72. Pennsylvania MISA Consortium. Report and Recommendations. OMHSAS, Harrisburg. August, 1999.
73. Peters RH & Bartoi, MG. Screening and Assessment of Co-occurring Disorders in the Justice System. National GAINS Center, Delmar, NY. 1997.
74. Peters RH & Hills HA. Intervention strategies for offenders with co-occurring disorders. What works?. National GAINS Center, Delmar, NY. 1997.
75. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am. Psychol. (1992) 47:1102-14.
76. Project Return. Mental Health Screening Form III. Project Return, New York. 2000.
77. Quinlivan R & McWhirter DP. Designing a comprehensive care program for high cost clients in a managed care environment. Psych Services (1996) 47:813-5.
78. RachBeisel, J, Scott, J. & Dixon, L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psych Services (1999). 50:1427-34.
79. Regier, DA, Farmer ME, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA (1990) 264:2511-18.
80. Ridgely, MS, Lambert, D, et al. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder. Psych Services (1999) 49:236-8.
81. Ries, RK & Comtois KA. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schiz. Bull. (1997a) 23:239-46.
82. Ries, RK & Comtois KA. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid substance disorder. Am. J. Addictions (1997b) 6(4):330-8.
83. Ries, RK, Russo, J, et al. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psych Services. 2001. 52(2):210-4.
84. Roberts LJ, Shaner A, & Eckman TA. Overcoming addictions: skills training for people with schizophrenia. W.W. Norton, New York. 1999.
85. Sacks, S. Co-occurring disorders: promising approaches and research issues. J. Substance Use & Misuse (2001), in press.
86. Sacks, S, Sacks, JY, & DeLeon G. Treatment for MICAs: design and implementation of the modified TC. J. Psychoactive Drugs. (1999) 31:19-30.
87. SAMHSA. Position statement on use of block grant funds to treat people with co-occurring disorders. 2000.
88. Sciacca, K. Sciacca Comprehensive Service Development and Curriculum for MIDAA. Materials available on dual diagnosis website: http://pobox.com/~dualdiagnosis. E-mail. Ksciacca@pobox.com.
89. Shaner A, Roberts LJ, et al. Monetary reinforcement of abstinence from cocaine among mentally ill persons with cocaine dependence. Psych Services (1997) 48:807-10.
90. Sowers, W & Golden, S. Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. J. Psychoactive Drugs. (1999) 31:59-67.
91. Texas Department of MH/MR. Co-occurring psychiatric and substance disorders: principles for programming and treatment in state mental health facilities. TDMHMR, Austin. 2000.
92. Tollefson GD, Montague-Clouse J, & Tollefson SL. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J. Clin. Psychopharm. (1992) 12:19-26.
93. Tsemberis, S & Eisenberg, RF. Pathways to Housing: Supported housing for street dwelling homeless individuals with psychiatric disabilities. Psychiatric Services (2000). 51(4):487-95.
94. Vogel, H. Double Trouble in Recovery (DTR): How to start and run a DTR group. NY Office of Mental Hygiene, Mental Health Empowerment Project, Albany 1999.
95. Weiss R, et al. Integrated dual recovery curriculum for bipolar disorder and addiction. McLean Hospital, Belmont, MA.
96. WELL Project. Principles for the trauma informed treatment of women with co-occurring mental health and substance abuse disorders. WELL Project, Cambridge, MA 1999.
97. Wilens, TE, Spencer, TJ, et al. A controlled clinical trial of bupropion for adult ADHD. Am J. Psych (2001) 158:282-88.
98. Ziedonis D & Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schiz. Bull. (1997) 23:229-38.
99. Zimmet SV, Strous RD, et al. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorders. J. Clin. Psychopharm (2000) 20:94-8.